The Scientist

» Scripps

Most Recent

image: California Institutes to Merge

California Institutes to Merge

By | October 25, 2016

The Scripps Research Institute will join forces with the California Institute for Biomedical Research.

0 Comments

image: New Scripps Research Institute Leadership

New Scripps Research Institute Leadership

By | September 20, 2015

The nonprofit institution names a new CEO and president.

0 Comments

image: Scripps’s President Steps Down

Scripps’s President Steps Down

By | July 23, 2014

Following widespread disapproval among faculty members, Scripps’s Michael Marletta resigns his post.

1 Comment

image: Scripps Scuttles USC Takeover

Scripps Scuttles USC Takeover

By | July 11, 2014

The Scripps Research Institute and the University of Southern California have ceased negotiations about a possible merger or acquisition.

0 Comments

image: Scripps Faculty Wants President Out

Scripps Faculty Wants President Out

By | July 7, 2014

Some faculty members of the Scripps Research Institute are wary of a possible merger with USC and would like to oust the organization’s president.

1 Comment

image: USC to Merge with Scripps?

USC to Merge with Scripps?

By | June 18, 2014

Rumors are swirling that the University of Southern California may acquire The Scripps Research Institute.

1 Comment

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham